Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

Other authors

Institut Català de la Salut

[de Las Heras B] Covance Inc., Princeton, NJ, USA. Madrid Medical Doctors Association, Madrid, Spain. [Saini KS] Covance Inc., Princeton, NJ, USA. East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK. [Boyle F] Mater Hospital, Sydney, Australia. [Ades F] Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. [de Azambuja E] Institut Jules Bordet, Brussels, Belgium. Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. [Bozovic-Spasojevic I] Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. [Capelan M] Vall d'Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2021-11-05T11:36:58Z

2021-11-05T11:36:58Z

2020-12



Abstract

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Càncer; Immuno-oncologia


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cáncer; Inmuno-oncología


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cancer; Immuno-oncology


The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future.


No funding was received from any source. No Rapid Service Fee was received by the journal for the publication of this article.

Document Type

Article


Published version

Language

English

Publisher

Springer

Related items

Oncology And Therapy;8

https://doi.org/10.1007/s40487-020-00124-2

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)